Sort
21,281 grants matching “influenza”
Mechanisms and Enviromental Determinants of Rhinovirus Illness Severity
$1,479,483James E. Gern · University Of Wisconsin-Madison · U19 · FY2013 · AI
International Research in Cambodia: Tropical Medicine and Vector Research
$1,479,224Christina Yek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Immune Regulation of Virus Clearance and Tissue Injury at Sites of Infection
$1,478,707Thomas J Braciale · University Of Virginia · U19 · FY2013 · AI
Seasonal Influenza Vaccine Effectiveness in a Tropical Developing African Country
$1,478,000John Christian Victor · Path · U01 · FY2010 · IP
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,477,795Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Task V2: Clinical Sample Testing from Influenza Clinical Trials for HAI, MN and NA Activity
$1,477,780Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2020 · AI
Self-administered microneedle patches for influenza vaccines
$1,476,869Richard W Compans · Emory University · U01 · FY2010 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$1,474,608Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2017 · AI
Collaborative Influenza Vaccine Innovation Centers STATISTICAL, DATA MANAGEMENT AND COORDINATION CENTER (SDMCC)
$1,473,868Stephan Bour · Digital Infuzion, Inc. · N01 · FY2021 · AI
Micro-Particle Delivery of a Potent Intracellular Adjuvant for a Universal Flu Vaccine
$1,473,686Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AI
Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance
$1,471,612Sue Huang · Inst Of Environmental Science & Research · U01 · FY2015 · IP
Developing Teixobactin for Respiratory Infections
$1,469,494Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R01 · FY2021 · AI
Immunostimulatory Patch To Enhance Biodefense Vaccines
$1,467,294Iomai Corporation · U01 · FY2005 · AI
Stanford/UNC Biomimetic U19 Research Center
$1,466,585Calvin J Kuo · Stanford University · U19 · FY2025 · AI
1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)
$1,466,425Fernando D Martinez · University Of Arizona · UG3 · FY2020 · HL
Mechanisms Of Humoral Evasion
$1,466,332Tongqing Zhou · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Understanding Risk of Zoonotic Virus Emergence in EID Hotspots of Southeast Asia
$1,464,739Peter Daszak · Ecohealth Alliance, Inc. · U01 · FY2023 · AI
SBIR Phase II: A novel and cost effective mechanical ventilator for pandemic preparedness and emergency stockpiling
$1,463,132Matthew Callaghan · Onebreath, Inc. · · FY2014 · TIP
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses
$1,460,645Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
NOVEL CELLULAR AND VIRAL TARGETS FOR ANTI-INFLUENZA VIRUS DRUGS
$1,460,196Peter Palese · Icahn School Of Medicine At Mount Sinai · U01 · FY2010 · AI
Innate inflammatory responses during pulmonary infections
$1,460,145Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death
$1,460,069Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$1,459,624Richard Rothman · Johns Hopkins University · N01 · FY2018 · AI
Synthesis of Effective and Safe Mucolytics for Pulmonary Disease
$1,459,479Richard C Boucher · Univ Of North Carolina Chapel Hill · UH2 · FY2014 · HL
Drivers of individual variation in influenza vaccine response and protection from infection
$1,455,916Sarah Cobey · University Of Chicago · R01 · FY2023 · AI